Merck has shared data from the pivotal Phase 3 trial evaluating the subcutaneous administration of pembrolizumab together ...

Curium Pharma, a developer, manufacturer, and distributor of nuclear medicine, has acquired Eczacıbaşı-Monrol Nuclear ...

Novo Nordisk has entered into an exclusive license agreement with Lexicon Pharmaceuticals Inc. for LX9851, a first-in-class, ...

Balancing safety and convenience, innovative stick pack designs offer a patient-centric solution for on-the-go dosage forms.

How innovation, advanced manufacturing, and expertise drive success in the evolving CDMO and generics landscape.

BioDuro has opened a new lab in Shanghai, China for highly potent compound synthesis at the hundred-gram scale.

Linearis has inaugurated a new laboratory in the greater Quebec City region and introduced its high-throughput metabolomics ...

National Resilience Inc., a technology-focused biomanufacturing company, is initiating the next phase of its growth in the ...

Navigating compliance challenges and technology solutions under DSCSA.

The FDA has approved GSK’s Blujepa for the treatment of female adults and pediatric patients with uncomplicated urinary tract ...

BSI’s goal is to make QS-21 accessible to a wider range of vaccines and populations, particularly in low-income countries.

Investment includes agreements with Harbour BioMed, Syneron Bio and BioKangtai
.